Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

Ardea Biosciences Acquires Valeant's Early Programs

Dec. 27, 2006

By Trista Morrison

EpiCept Licenses Bupivacaine Patch IP To Durect For $10M

Dec. 27, 2006

By Trista Morrison

Genzyme Submitting NDA For Renvela, Eying Broader Sales

Dec. 22, 2006

By Trista Morrison

Genzyme Submitting NDA For Renvela, Eying Broader Sales

Dec. 22, 2006

By Trista Morrison

Neurogen Raises $40M To Drive Forth Phase II Trials

Dec. 20, 2006

By Trista Morrison

Neurogen Raises $40M To Drive Forth Phase II Trials

Dec. 20, 2006

By Trista Morrison

Durect, Nycomed Agree On Pain Drug Marketing Deal

Dec. 1, 2006

By Trista Morrison

Shares of Durect Corp. rose nearly 50 percent in after-close trading Wednesday based on a $202 million marketing deal between the Cupertino, Calif.-based company and Roskilde, Denmark-based Nycomed A/S. (BioWorld Today)

Durect, Nycomed Agree On Pain Drug Marketing Deal

Dec. 1, 2006

By Trista Morrison

Shares of Durect Corp. rose nearly 50 percent in after-close trading Wednesday based on a $202 million marketing deal between the Cupertino, Calif.-based company and Roskilde, Denmark-based Nycomed A/S. (BioWorld Today)

Targeted Genetics' Share Price, Volume Jump Go Unexplained

Nov. 30, 2006

By Trista Morrison

Targeted Genetics' Share Price, Volume Jump Go Unexplained

Nov. 30, 2006

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...